Trends in hospice utilization and place of death preferences in multiple myeloma-related deaths from 2003 to 2020: Analysis of CDC Wonder database.
Muhammad Salman Faisal(University of Oklahoma Health Sciences Center), Faiz Anwer(Cleveland Clinic), Noha Soror(University of Oklahoma Medical Center), Atulya Aman Khosla(Baptist Hospital of Miami), Rahul Mishra(Anne Arundel Medical Center), Madhan Srinivasan Kumar(Saint Vincent Hospital), Nitya Batra(Jacksonville College), Karan Jatwani(Roswell Park Comprehensive Cancer Center), Zain Ishtiaq Ahmad(University of Exeter), Mahnoor Sukaina(Karachi Medical and Dental College)
Cited by 2
Related Papers
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
|Nature Medicine|2023|239
Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
|Blood Reviews|2018|192
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80